Search Results - "JONKERS, Ijam"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia by Jonkers, Iris J A M, Smelt, Augustinus H M, Princen, Hans M G, Kuipers, Folkert, Romijn, Johannes A, Boverhof, Renze, Masclee, Ad A M, Stellaard, Frans

    Published in The Journal of nutrition (01-04-2006)
    “…Fibrates are drugs of choice in patients with hypertriglyceridemia (HTG), but may increase the risk for gallstones by decreasing bile acid synthesis. Fish oil…”
    Get more information
    Journal Article
  2. 2

    Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy by Jonkers, Iris J A M, Smelt, Augustinus H M, Hattori, Hiroaki, Scheek, Leo M, van Gent, Teus, de Man, Frits H A F, van der Laarse, Arnoud, van Tol, Arie

    Published in Journal of lipid research (01-08-2003)
    “…Hypertriglyceridemia (HTG) is associated with insulin resistance, increased cholesteryl ester transfer (CET), and low HDL cholesterol. Phospholipid transfer…”
    Get full text
    Journal Article
  3. 3

    Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil by Jonkers, I J A M, Smelt, A H M, Ledeboer, M, Hollum, M E, Biemond, I, Kuipers, F, Stellaard, F, Boverhof, R, Meinders, A E, Lamers, C H B W, Masclee, A A M

    Published in Gut (01-01-2003)
    “…Background and aim: The aim of this study was to unravel the mechanisms responsible for the increased risk of gall stone disease in hypertriglyceridaemia (HTG)…”
    Get full text
    Journal Article
  4. 4

    Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals by HOFMAN, M. K, GROENENDIJK, M, VERKUIJLEN, Pjjh, JONKERS, Ijam, MOHRSCHLADT, M. F, SMELT, A. H. M, PRINCEN, H. M. G

    Published in European journal of human genetics : EJHG (01-11-2004)
    “…The rate-limiting enzyme in the conversion of cholesterol into bile acids is cholesterol 7alpha-hydroxylase (CYP7A1). An A to C substitution 278 bp upstream in…”
    Get full text
    Journal Article
  5. 5

    Implication of fibrate therapy for homocysteine by Jonkers, IJAM, de Man, FHAF, Onkenhout, W, van der Laarse, A, Smelt, AHM

    Published in The Lancet (British edition) (02-10-1999)
    “…To identify a possible effect of bezafibrate on renal function, serum creatinine was assessed, 24 h urine was collected for measurement of urinary creatinine,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Effects of very long chain versus long chain triglycerides on gastrointestinal motility and hormone release in humans by JONKERS, I. J. A. M, LEDEBOER, M, STEENS, J, SMELT, A. H. M, MASCLEE, A. A. M

    Published in Digestive diseases and sciences (01-09-2000)
    “…Fish oil (a very long chain triglycerides, VLCT) has received much attention because of its favorable metabolic properties; however, its effect on…”
    Get full text
    Journal Article
  8. 8

    Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a ‘procoagulant state': effects of bezafibrate therapy by Jonkers, I J. A. M, de Man, F H. A. F, van Tilburg, N H, van der Laarse, A, Sandset, P M, Smelt, A H. M, Bertina, R M

    Published in Blood coagulation & fibrinolysis (01-12-2001)
    “…Hypertriglyceridemia (HTG) is an independent risk factor for cardiovascular disease (CVD). Hemostatic variables [factor VII antigen (FVIIag), factor VII…”
    Get full text
    Journal Article
  9. 9

    High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age by Weverling-Rijnsburger, Annelies W E, Jonkers, Iris J A M, van Exel, Eric, Gussekloo, Jacobijn, Westendorp, Rudi G J

    Published in Archives of internal medicine (1960) (14-07-2003)
    “…A high total serum cholesterol level does not carry a risk of cardiovascular mortality among people 85 years and older and is related to decreased all-cause…”
    Get more information
    Journal Article